• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4624960)   Today's Articles (32)   Subscriber (49469)
For: Braillon A, Taiebi F, Bernoussi A. Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence? Clin Drug Investig 2018;38:385-386. [DOI: 10.1007/s40261-018-0628-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Number Cited by Other Article(s)
1
Braillon A. Nalmefene as Needed Use Needs Evidence for Harm/Benefit Ratio. Alcohol Alcohol 2020;55:337. [DOI: 10.1093/alcalc/agaa015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
2
Drugs for treatment for alcohol use disorders expose to interactions with others … for little benefit if any. Pharmacol Res 2018;134:156. [DOI: 10.1016/j.phrs.2018.06.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 06/15/2018] [Accepted: 06/24/2018] [Indexed: 11/23/2022]
3
Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A. Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence? Clin Drug Investig 2018;38:387-388. [DOI: 10.1007/s40261-018-0625-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA